CD86 and neoplasm: Application of AXL inhibitors to treat mice resulted in delayed tumor growth, elevated rate of effector memory helper T cells, enhanced infiltration of central memory cytotoxic T cells, increased amounts of CD86+ macrophages, and elevated proportion of CD80 high-expression macrophages in the tumor model (113).